The Fibrinolytic Efficacy and Impact on Plasma von Willlebrand Factor of Losartan Compared with Atenolol in Essential Hypertensives
- VernacularTitle:氯沙坦和阿替洛尔对高血压患者纤溶系统及血浆血管性血友病因子的作用比较
- Author:
Jing LIU
;
Ningling SUN
- Publication Type:Journal Article
- Keywords:
Hypertension;
Losartan;
Atenolol;
Fibrinolytic system;
Plasma von willlebrand factor
- From:
Chinese Journal of Hypertension
2007;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Objectives To compare the effects of losartan and atenolol on fibrinolytic system and plasma von willebrand factor (vWF) in patients with essential hypertension. Methods Sixty patients with mild to moderate essential hypertension were randomized to receive lostartan(50 mg/d, n=30) or atenolol(50 mg/d, n=30) for 8 weeks. If the goal blood pressure(
